Calorie restriction increases serum parathyroid hormone and decreases serum calcitonin levels in patients with maturity onset diabetes mellitus
- 28 Downloads
Calorie restriction is important in managing patients with maturity onset diabetes mellitus (NIDDM). The effect of such restriction on calcium metabolism is not known. The objective of this study was to determine whether patients on calorie restricted diets would show any modification of parathyroid hormone (PTH) and calcitonin (CTN).
The serum levels of PTH and CTN were measured by radioimmunoassays in 269 patients with NIDDM. The patients were divided into two groups depending on the intake of calorie, and PTH and CTN were monitored for 2 years. Plasma levels of vitamin D were measured by competitive protein binding assays before and after each program.
The level of PTH (520.8±266.0 pg/ml) (mean±S.D.) was significantly (P<0.01) higher in 109 diabetic patients whose calorie intake was restricted for 2 years (diet (D) group) as compared with that (256.6±103.8 pg/ml) of 160 diabetic patients whose calorie intake was not restricted (non-diet (ND) group). The daily oral calcium intake of the two groups did not differ significantly. We found no significant difference in the serum PTH level in the ND groupVS. normal control subjects (248.8±98.4, N=78). The serum calcium concentration and the amount of calcium excreted in urine were slightly but significantly (P<0.01) lower in the D than in the ND group. The rate of tubular reabsorption of phosphate (% TRP) was significantly lower in the D group than that in the ND group (P<0.01). The serum CTN level was significantly (P<0.01) lower in the D group (33.9±11.3 pg/ml) than in the ND group (64.9±21.2 pg/ml) 2 years after each treatment. The plasma 1,25-(OH)2-vitamin D level was significantly (P<0.01) lower in the D group (22.2±6.6 pg/ml) than in the ND group (50.6±4.2 pg/ml). When the restriction of calorie intake in the D group was canceled, their PTH levels decreased, which was accompanied by increase in the 1,25-(OH)2-vitamin D levels, whereas their CTN levels were unchanged.
These observations suggested that a restricted calorie intake is a risk factor for secondary hyperparathyroidism as well as for a low serum level of CTN in patients with NIDDM.
Key WordsMaturity-onset diabetes mellitus (NIDDM) Parathyroid hormone (PTH) Calcitonin (CTN) Vitamin D Calorie restriction
Unable to display preview. Download preview PDF.
- 1.Cooppan, R. and Flood, T.M.: Obesity and Diabetes.In: Joslin's Diabetes Mellitus, 12th edition. (A. Marble, L.P. Krall, R.F. Bradley, A.R. Christlieb and J.S. Soeldner, editors), Lea & Febiger, Philadelphia. 373–379, 1985.Google Scholar
- 2.Flood, T.M., Halford, B.N., Cooppan, R. and Marble, A.: Dietary management of diabetes.In: Joslin's Diabetes Mellitus, 12th edition. (A. Mable, L.P. Krall, R.E. Bradley, A.R. Christlieb and J.S. Soeldner, editors), Lea & Febiger, Philadelphia. 357–372, 1985.Google Scholar
- 3.Fajans S.S.: Diabetes mellitus: Classification and testing procedures.In: Endocrinology, 2nd edition. (L.J. DeGroot, G.F. Cahill Jr., J.C. Marshall, D.H. Nelson, W.D. Odell, J.T. Potts Jr., A.H. Rubenstein, A.H. Steinberger, and L. Martini, editors), W.B.Saunders, Philadelphia. 1346–1356, 1989.Google Scholar
- 6.Gertner, J.M., Tamborlane, W.V., Horst, R.L., Sherwin, R.S., Felig, P. and Genel, M.: Mineral metabolism in diabetes mellitus: changes accompanying treatment with a portable subcutaneous insulin infusion system. J. Clin. Endocrenol. Metab. 50: 862–866, 1980.Google Scholar
- 7.Frazer, T.E., White, N.H., Hough, S., Santiago, J.V., McGee, B.R., Bryce, G., Mallon, J. and Avioli, L.V.: Alterations in circulating vitamin D metabolites in the young insulin-dependent diabetic. J. Clin. Endocrinol. Metab. 153: 1154–1159, 1981.Google Scholar
- 8.Witt, M.E., White, N.H., Santiago, J.V., Seino, Y. and Avioli, L.V.: Use of oral calcium loading to characterize the hypercalciuria of young insulin-dependent diabetics. J. Clin. Endocrinol. Metab. 57: 94–100, 1982.Google Scholar
- 10.Haddad, J.G. and Chyu, K.J.: Competitive protein-binding radioassay for 25-hydroxycholecalciferol. J. Clin. Endocrinol. Metab. 33: 992–995, 1974.Google Scholar
- 14.Genant, H.K., Cann, C.E. and Bruce, E.: Quantitative computed tomography of vertebral spongiosa: A sensitive method for detecting early bone loss after oophorectomy. Annals. Int. Med. 97: 699–705, 1982.Google Scholar
- 23.Mahaffey, J.E. and Potts Jr., J.T.: Secondary hyperparathyroidism: Pathophysio-logy and etiology.In: Endocrinology, first edition. (L.J. DeGroot, G.F. Cahill, and W.D. Odell, eds.) New York: Grune and Stratton, 739–749, 1979.Google Scholar
- 24.Buckle, R.M., Aurbach, G.D. and Potts Jr., J.T.: Adaptive increases in parathyroid glandular activity.In: Protein and Polypeptide Hormones. Excerpta Medica International Congress Series No. 161. Amsterdam, Excepta Medica, 389–395, 1969.Google Scholar
- 26.Willis, M.R., Pak, C.Y.C., Hammond, W.G. and Bartter, F.C.: Normocalcemic primary hyperparathyroidism. Am. J. Med. 47: 384–391, 1969.Google Scholar
- 27.Dietel, M., Dorn, G., Montz, R. and Altenahr, E.: Influence of vitamin D3, 1,25-dihydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3′,5′-monophosphate release, and ultrastructure of parathyroid glands in organ culture. Endocrinology 105: 237–245, 1979.PubMedGoogle Scholar
- 33.Marcus, R., Madvig, P. and Young, G.: Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J. Clin. Endoccrinol. Metab. 58: 223–230, 1984.Google Scholar
- 35.Kumar, M.A., Foster, G.V. and MacIntyre, I.: Further evidence for calcitonin, a rapid-acting hormone which lowers plasma calcium. Lancet 2: 480–482, 1963.Google Scholar
- 40.Stevenson, J.C.: Regulation of calcitonin and parathyroid hormone secretion by estrogens. Meturitas 4: 1–7, 1982.Google Scholar